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We incorporate a new section in Redox Biology, the Editors'
forum. The main objective is to attract short contributions related
to previously published articles that may help to clarify concepts,
open controversies or constructively criticize conclusions from a
speciﬁc article. The contribution will show a link to the related
article and may be accompanied by the appropriate response of
the authors to the commentary on their article.
The article by Drs. Cortese-Krott and Kelm [1] promoted an
extensive analysis by Dr. Tsikas about the optimal methodology to
characterize eNOS activity in red blood cells and its relevance
for the concepts put forward by Cortese-Krott and Kelm. The
authors were given the opportunity to respond to this commen-
tary and their answer is shown below the commentary. Indeed
this is an important question as the jury appears to be still out
concerning the existence of a NOS isoform in human red blood
cells. Dr. Tsikas makes a strong case on the validity of the gas
chromatography-mass spectrometry (GC-MS) NOS activity assay
for a large set of samples, including erythrocytes, and delves into
the complex chemistry involved. Drs. Cortese-Krott and Kelm
lucidly respond to Dr. Tsikas with equally powerful arguments.
We are proud to host this illuminating discussion on a complex
chemical topic and we invite all readers to follow this example and
submit commentaries that may contribute to enhance progress in
the understanding of challenging notions in the ﬁeld of redox
biology.
http://dx.doi.org/10.1016/j.redox.2015.01.018
Can nitric oxide synthase activity be unequi-
vocally measured in red blood cells and
platelets? If yes, by which assay?
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To the Editor
I read with interest the article by Cortese-Krott and Kelm [1]
who reviewed and discussed the at ﬁrst glance paradoxical, yet
potentially important and formidably challenging issue of nitric
oxide (NO) synthesis from L-arginine by endothelial NO synthase
(eNOS) in red blood cells (RBCs), a possibly new erythrocrine
function. In consideration of the high concentration of hemoglobin
in erythrocytes (about 10 mM) and the high afﬁnity of O2, NO and
carbon monoxide (CO) and presumably of other gases to the heme
group of hemoglobin, the majority of scientists believes that RBCs
behave toward NO as do super-massive black holes behave against
matter and even light, with other words as “NO sinks”. Yet, in
practice we see that RBCs are able to export NO and other NO
species that can ﬁnally exert cGMP-dependent and cGMP-
independent NO-related activities in the circulation. With respect
to this issue I fully agree with the statements, arguments and
conclusions by Cortese-Krott and Kelm in their review article [1].
However, I do not agree with the authors on their argument
concerning the alleged chemistry of NOS-derived NO in RBCs and
that this particular NO chemistry may explain our failure to
measure NOS activity in human RBCs by means of a previously
reported, fully-validated [2] and cross-validated [3] gas chromato-
graphy–mass spectrometry (GC–MS) NOS activity assay.
The principle of our GC–MS NOS activity assay [2] used in vivo
and in vitro in blood cells including human RBCs [4] and platelets
[3,5] and the major reactions of NO and its major metabolites/
reaction products, nitrate and nitrite, are illustrated in Fig. 1. We
use L-[guanidino-15N2]-arginine as the substrate for NOS which
oxidizes one of the two 15N-labeled atoms of L-[guanidino-15N2]-
arginine to 15NO, with L-[ureido-15N]-citrulline being the second
reaction product. Because authentic 15NO is not detectable at low
NOS activity values as in the case of endothelial NOS (eNOS),
analytically accessible metabolites/reaction products of 15NO are
analyzed instead. It must be emphasized that all eNOS activity
assays are exclusively based on the measurement of NO metabo-
lites/reaction products because of the pretty low NO formation
rate. In aqueous solutions including blood 15NO is autoxidized to
15N-nitrite (15NO2), albeit to a minor extent [6]. NOS isozymes are
able to oxidize its own 15NO to 15N-nitrate (O15NO2) [3]. In
aqueous solutions of recombinant eNOS solutions and in washed
human platelets suspensions, the 15NO2-to-O15NO2 molar ratio is
about 1:1 [5]. In human erythrocytes suspensions in regular
buffers of neutral pH value or in whole blood [6], 15NO-derived
15NO2 is practically undetectable, because 15NO is rapidly oxidized
by oxyhemoglobin (HbFeIIO2) to O15NO2 . Thus, in RBCs eNOS
would convert L-[guanidino-15N2]-arginine to 15NO which would
be oxidized to O15NO2 largely by HbFeIIO2 and to a minor extent
by eNOS (Fig. 1). In theory, a very small fraction of L-[guanidi-
no-15N2]-arginine/eNOS-derived 15NO would autoxidize to 15NO2
which would almost uniformly partition between plasma and
RBCs. Erythrocytic 15NO2 would ﬁnally be oxidized to O15NO2
by HbFeIIO2. This is supported by our observation that synthetic
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